Medicus Pharma (MDCX) Net Cash Flow (2024 - 2025)

Medicus Pharma (MDCX) reported Net Cash Flow of $44355.0 for Q4 2025, up 103.88% on a YoY basis from $21755.0 in Q4 2024, and down 98.77% quarter-over-quarter from $3.6 million in Q3 2025.

Medicus Pharma (MDCX) Net Cash Flow (2024 - 2025) Analysis & Trends

Medicus Pharma has reported Net Cash Flow for 2 years, with the latest figure at $44355.0 in Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 103.88% year-over-year to $44355.0; the trailing twelve-month figure through Dec 2025 stood at $9.2 million (up 274.77% YoY), and the FY2025 full-year result was $4.5 million, up 85.84% from the prior year.
  • Net Cash Flow for Q4 2025 stood at $44355.0, down from $3.6 million in the prior quarter.
  • The five-year high for Net Cash Flow was $7.9 million in Q2 2024, with the low at -$3.1 million in Q3 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 210.32 Mn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -2.05 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 2.00 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 4.17 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -9.27 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 2.91 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 75.00 Mn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 544.00 Mn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -587.00 Mn
10 Medicus Pharma 7.87 Mn 7.98 Mn - 44,355.00

Historic Data

Download Data
DateValue
Dec 31, 2025 44,355.00
Dec 31, 2025 44,355.00
Sep 30, 2025 3.61 Mn
Sep 30, 2025 3.61 Mn
Jun 30, 2025 5.69 Mn
Jun 30, 2025 5.69 Mn
Mar 31, 2025 -181,893.00
Mar 31, 2025 -181,893.00
Dec 31, 2024 -1.14 Mn
Dec 31, 2024 -1.14 Mn
Sep 30, 2024 -3.10 Mn
Sep 30, 2024 -3.10 Mn
Jun 30, 2024 7.87 Mn
Jun 30, 2024 7.87 Mn
Mar 31, 2024 -1.18 Mn
Mar 31, 2024 -1.18 Mn